Endometriosis. Guideline of European Society of Human Reproduction and Embryology – 2022

In: REPRODUCTIVE ENDOCRINOLOGY · 2022 · pp. 8–19 · doi:10.18370/2309-4117.2022.66.8-19 · W4313271526
article OA: diamond CC0 ⤵ 9 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

The 2022 ESHRE guideline provides clinical recommendations for the diagnosis and treatment of endometriosis, covering symptom relief, infertility, and special patient populations based on available evidence and consensus.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-17 · read from full text

The European Society of Human Reproduction and Embryology developed this clinical practice guideline to improve healthcare delivery for women with endometriosis. The document provides evidence-based recommendations for secondary and tertiary care providers regarding the diagnosis, treatment, and management of painful symptoms and infertility associated with the condition. It also addresses specific populations such as adolescents and menopausal women, while acknowledging gaps in scientific evidence where consensus was required. This paper is centrally about endometriosis — specifically providing comprehensive clinical guidelines for its diagnosis, symptom relief, and fertility management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The European Society of Human Reproduction and Embryology (ESHRE) developed the current clinical practice guideline, to provide clinical recommendations to improve the quality of healthcare delivery within the European field of human reproduction and embryology. This guideline represents the views of ESHRE, which were achieved after careful consideration of the scientific evidence available at the time of preparation. In the absence of scientific evidence on certain aspects, a consensus between the relevant ESHRE stakeholders has been obtained. This document is the second update of the ESHRE Guidelines on Endometriosis (2014). However, there still remain many unanswered questions for which no, or only poor quality or little data are available.The aim of clinical practice guidelines is to aid healthcare professionals in everyday clinical decisions about appropriate and effective care of their patients. The guideline covers the care provided by secondary and tertiary healthcare professionals who have direct contact with, and make decisions concerning, the care of women with endometriosis. Although primary healthcare providers are not the main target users of this guideline, it may be of interest for them too.This guideline offers best practice advice on the care of women with suspected and confirmed endometriosis. Recommendations are provided on diagnosis and treatment for both relief of painful symptoms and for infertility due to endometriosis.Specific recommendations are provided on management of patients in whom endometriosis is found incidentally (without pain or infertility), adolescents and menopausal women with endometriosis.Information on risk factors for endometriosis and associations with other diseases is provided, with recommendations on prevention and monitoring.
Full text 2,912 characters · extracted from oa-doi-fallback · click to expand
Endometriosis. Guideline of European Society of Human Reproduction and Embryology – 2022 DOI: https://doi.org/10.18370/2309-4117.2022.66.8-19Keywords: endometriosis, guideline, European Society of Human Reproduction and EmbryologyAbstract The European Society of Human Reproduction and Embryology (ESHRE) developed the current clinical practice guideline, to provide clinical recommendations to improve the quality of healthcare delivery within the European field of human reproduction and embryology. This guideline represents the views of ESHRE, which were achieved after careful consideration of the scientific evidence available at the time of preparation. In the absence of scientific evidence on certain aspects, a consensus between the relevant ESHRE stakeholders has been obtained. This document is the second update of the ESHRE Guidelines on Endometriosis (2014). However, there still remain many unanswered questions for which no, or only poor quality or little data are available. The aim of clinical practice guidelines is to aid healthcare professionals in everyday clinical decisions about appropriate and effective care of their patients. The guideline covers the care provided by secondary and tertiary healthcare professionals who have direct contact with, and make decisions concerning, the care of women with endometriosis. Although primary healthcare providers are not the main target users of this guideline, it may be of interest for them too. This guideline offers best practice advice on the care of women with suspected and confirmed endometriosis. Recommendations are provided on diagnosis and treatment for both relief of painful symptoms and for infertility due to endometriosis. Specific recommendations are provided on management of patients in whom endometriosis is found incidentally (without pain or infertility), adolescents and menopausal women with endometriosis. Information on risk factors for endometriosis and associations with other diseases is provided, with recommendations on prevention and monitoring. Downloads Published How to Cite Issue Section License Copyright (c) 2022 Група з розробки рекомендацій з ендометріозу ESHRE This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK